Toshihiko Aranishi

11PUBLICATIONS
24CO-AUTHORS
Nutritional epidemiologyMajor global burdens of diseasePharmacogenomicsSocial epidemiologyTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 07, 2025
Correction to: The Long-Term Cost-Effectiveness of Tirzepatide 5 mg versus Dulaglutide 0.75 mg for the Treatment of People with Type 2 Diabetes in Japan.

Toshihiko Aranishi, Ataru Igarashi, Kazuo Hara

|Dec 21, 2024
The Long-Term Cost-Effectiveness of Tirzepatide 5 mg versus Dulaglutide 0.75 mg for the Treatment of People with Type 2 Diabetes in Japan.

Toshihiko Aranishi, Ataru Igarashi, Kazuo Hara

|Dec 14, 2022
Impact of Patient and Physician Disconnect on Satisfaction with Treatment for Atopic Dermatitis in Japan.

Chaochen Wang, Toshihiko Aranishi, Catherine Reed

|Mar 09, 2022
Current status of shared decision making for rheumatoid arthritis treatment in Japan: a web-based survey on physicians and patients.

Hiroto Tsuboi, Yuko Kaneko, Kei Ikeda

Pageof 2